-
University of Aberdeen spinout success
The University of Aberdeen has been ranked 10th in the UK for life sciences spinouts by business analyst organisation Beauhurst.
-
New study shows seafood supplies don't always satisfy dietary recommendations
A new study has found that for many European countries - including the UK - there is not a large enough fish supply to meet the recommended national dietary requirements.
-
Huntington's disease cases in Northern Scotland up nearly 50% in 30 years
The number of people with a diagnosis of Huntington's disease (HD) in Northern Scotland has increased by almost 50% over the last 30 years according to a new University of Aberdeen study.
-
Major boost to train the next generation of trials methodologists
A partnership to train the next generation of trials methodologists has been awarded funding by the Medical Research Council through their Doctoral Training Partnership (DTP) competition.
-
New short course hopes to improve women's healthcare around the world
A new online course that will explore global women's health issues has been launched at the University of Aberdeen.
-
Governments hail progress on transformational Aberdeen BioHub
£40m project will make Aberdeen "one of the UK's most dynamic life sciences locations"
-
Scientists develop 'game-changing' antibody test
Antibody tests that can detect whether people have been exposed to new variants of Covid-19 have been developed by the University of Aberdeen, in collaboration with biotechnology group Vertebrate Antibodies Ltd and NHS Grampian.
-
Brainfood: Researchers find brain area associated with protein cravings
New research from scientists at the Universities of Aberdeen, Leicester and UiT, The Arctic University of Norway, has identified an area of the brain that may drive cravings for protein-rich food.
-
University appoints new Director of the Rowett Institute
The University of Aberdeen has appointed Professor Julian Griffin as the new Director of the Rowett Institute.
-
Covid vaccine linked to low platelet count, nationwide study suggests
A condition that affects the blood, known as idiopathic thrombocytopenic purpura (ITP), may be associated with the Oxford-AstraZeneca vaccine in rare cases, research suggests.